Long-Term Safety and Durability of Effect of Ecopipam in Pediatric Patients With Tourette Syndrome: Results of a 12-Month Open-Label Extension Study

Atkinson Sarah

Emalex Biosciences, Inc.
Donald L. Gilbert, David J.B. Kim, Meredith M. Miller, George B. Karkanias, Frederick E. Munschauer, Stephen P. Wanaski, Timothy M. Cunniff
Supported by:
Association Française du Syndrome de Gilles de LaTourette
Supporting video available
Listen to the audio presentation
View supporting document(s) shared by the author
Recommended links:
Contact author
Trophy icon
go back